📅 Date/Time:
September 22nd, 2026
9:00 a.m. - 3:30 p.m
📍Venue:
Hilton Garden Inn Seattle/Bothell
22600 Bothell Everett Hwy
Bothell, WA 98021
Join Agilent in person on September 22nd, 2026 in Bothell, WA, for a comprehensive biopharma seminar showcasing innovative analytical solutions that accelerate biotherapeutic development while advancing sustainability. This program brings together cutting-edge instrumentation, workflows, and applications—from liquid chromatography and high-resolution mass spectrometry to capillary electrophoresis and automated sample preparation. Attendees will gain insights into modern strategies for comprehensive characterization, critical quality attribute (CQA) monitoring, and improved separations, all aimed at enhancing efficiency, data quality, and regulatory confidence. The seminar also highlights Agilent’s commitment to embedding sustainability into scientific innovation, providing a forward-looking perspective on responsible biopharma research and development.
Manu Grover holds a postgraduate degree in Pharmacy and Management with 24+ years of experience in chromatography. He has worked with leading pharmaceutical companies, including Dr. Reddy’s, Panacea Biotec, and Ozone Pharmaceuticals, supporting IND, NDA, and ANDA filings. He specializes in analytical method development and validation using HPLC, GC, particle sizing, DSC, pXRD, and LC/MS, and has filed multiple analytical dossiers for EU markets. At Agilent Technologies, he leads strategic marketing initiatives and workflow programs for the pharmaceutical and biopharmaceutical sectors across North America and Canada, focusing on market trends, customer alignment, and targeted engagement.
Guannan Li joined Agilent as an application scientist in 2016. Guannan received her Ph.D. in medicinal chemistry from the University of Illinois at Chicago. Guannan supports biopharma applications.
Oscar Navarro is the Molecular Spectroscopy Product Specialist for the US - West Coast. He holds his Ph.D. in Organic Chemistry from the University of New Orleans and spent 12 years as a university professor, followed by several years working in the GMP biotech/CDMO space. After completing an Executive MBA at the Quantic School of Business and Technology, he transitioned into commercial roles, specializing in Process Analytics instrumentation, in companies like Nanalysis, Repligen, and now at Agilent.
Kenda received her Ph.D. from The University of Texas Health Science Center in San Antonio in the field of Pharmacology with a focus on the signal transduction pathway for the Serotonin 1A (5-HT1A) receptor. Kenda’s post-doctoral work occurred at the University of Houston School of Pharmacy where she studied the effects of inverse agonists and antagonists on Beta receptors in both respiratory and cardiovascular models. Kenda then joined Encysive Pharmaceuticals where she was the lead for the high throughput screening team as well as project manager for target drugs. Following this, Kenda joined PerkinElmer as a high throughput screening Field Application Scientist. For more than fourteen years now, Kenda has been a part of the Automation Team at Agilent and is currently in the role of Automation Workflow Specialist where she is helping researchers find the right solution for their automation needs and working to enable more fully applicated workflows.
Luzelva Shaw have been with Agilent Technologies for three years where I have helped biopharma labs across the Pacific Northwest and Midwest find solutions to their large molecule analytical challenges. I hold a Biology degree from Concordia University, a Master of Science from Texas State University, and have15 years of experience working in pharma and biopharma industry.
Quentin is our Market Specialist in the Northeast providing technical expertise for Agilent’s Automated Electrophoresis (AE) instrument suite, which includes the Fragment Analyzer, Femto Pulse, and the most recent addition to the group, the ProteoAnalyzer. His work over the past five years has been focused on supporting scientists gain novel insights from their proteomics analysis, and he leverages that experience in his current role centered around protein QC.
Bita is LC applications Scientist with Agilent Technologies. Prior to Agilent she was a contractor in Cytokinetics, metabolomics team, where she focused on detection and quantification of different targets in in-vivo samples, blood and tissue, using TQ and TOF. she was also a contractor in Merck SSF, Analytical Research & Development team, managing Open Access LC, LC/TOF, and LC/QTOF instruments for method development and automated processing. Her work in Merck also covered DAR analysis, and purity check QC. Her PhD in CAARES MS center in Clarkson University was focused on extraction, purification, detection, and quantification of small molecule contaminant in complex matrices mainly utilizing LC/QTOF.